LPL Financial
GMAB icon

LPL Financial’s Genmab GMAB Stock Holding History

LPL Financial’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.96M Sell
144,321
-44,316
-23% -$1.18M ﹤0.01% 3017
2026
Q1 		$5.06M Sell
188,637
-249,381
-57% -$7.47M ﹤0.01% 2606
2025
Q4 		$13.5M Buy
438,018
+66,762
+18% +$2.08M ﹤0.01% 1677
2025
Q3 		$11.4M Buy
371,256
+120,427
+48% +$2.93M ﹤0.01% 1749
2025
Q2 		$5.18M Buy
250,829
+46,455
+23% +$954K ﹤0.01% 2276
2025
Q1 		$4M Buy
204,374
+8,938
+5% +$187K ﹤0.01% 2340
2024
Q4 		$4.08M Buy
195,436
+6,288
+3% +$138K ﹤0.01% 2239
2024
Q3 		$4.61M Buy
189,148
+43,118
+30% +$1.15M ﹤0.01% 2068
2024
Q2 		$3.67M Buy
146,030
+14,040
+11% +$398K ﹤0.01% 2101
2024
Q1 		$3.95M Buy
131,990
+47,830
+57% +$1.41M ﹤0.01% 1963
2023
Q4 		$2.68M Buy
84,160
+22,222
+36% +$698K ﹤0.01% 2163
2023
Q3 		$2.18M Buy
61,938
+13,364
+28% +$509K ﹤0.01% 2221
2023
Q2 		$1.85M Buy
48,574
+1,107
+2% +$44.1K ﹤0.01% 2322
2023
Q1 		$1.79M Sell
47,467
-18,337
-28% -$705K ﹤0.01% 2229
2022
Q4 		$2.79M Buy
65,804
+6,358
+11% +$262K ﹤0.01% 1824
2022
Q3 		$1.91M Buy
59,446
+17,186
+41% +$603K ﹤0.01% 2023
2022
Q2 		$1.37M Buy
42,260
+2,048
+5% +$66.4K ﹤0.01% 2320
2022
Q1 		$1.46M Sell
40,212
-15,903
-28% -$546K ﹤0.01% 2302
2021
Q4 		$2.22M Buy
56,115
+4,895
+10% +$204K ﹤0.01% 2010
2021
Q3 		$2.24M Buy
51,220
+4,522
+10% +$203K ﹤0.01% 1955
2021
Q2 		$1.91M Sell
46,698
-36,573
-44% -$1.41M ﹤0.01% 2017
2021
Q1 		$2.73M Buy
83,271
+20,276
+32% +$763K ﹤0.01% 1625
2020
Q4 		$2.56M Buy
62,995
+14,924
+31% +$558K ﹤0.01% 1511
2020
Q3 		$1.76M Buy
48,071
+32,250
+204% +$1.17M ﹤0.01% 1538
2020
Q2 		$536K Buy
+15,821
New +$431K ﹤0.01% 2325

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

LPL Financial's GMAB Position: Q2 2026 in Review

LPL Financial reduced its Genmab (GMAB) stake by 23% in Q2 2026, selling an estimated $1.18M and leaving 144,321 shares worth $3.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

LPL Financial first reported a position in GMAB in Q2 2020 and has held it in 25 quarters since. The position peaked at $13.5M in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • LPL Financial held 144,321 shares of Genmab worth $3.96M as of Q2 2026.
  • LPL Financial sold 44,316 Genmab shares in Q2 2026, an estimated $1.18M.
  • Genmab made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3017 holding.
  • LPL Financial first reported a position in Genmab in Q2 2020 and has held it in 25 quarters since.
  • LPL Financial's Genmab position peaked at $13.5M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.